Clinical Variability in Spinal Muscular Atrophy Type <scp>III</scp>

Abstract

Our findings contribute to the understanding of the natural history of SMA type III and will be helpful in the interpretation of the real-world data of patients treated with commercially available drugs. ANN NEUROL 2020;88:1109-1117.